ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

Sister Study To Examine Risk Factors For Breast Cancer In 50,000 Women

October 29, 2004

ASCO: NCI Authorities Still Important

June 11, 2010

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014

In Brief: CCOP Formats To Be Available For Help In Writing Applications; Gale On Videotape

August 8, 1986